Bicocca Open Archive

Logo unimib boa
BOMBELLI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.233
AS - Asia 9.883
EU - Europa 7.199
SA - Sud America 1.434
AF - Africa 246
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 15
Totale 35.027
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.281
SG - Singapore 3.934
CN - Cina 2.054
IT - Italia 1.332
HK - Hong Kong 1.298
RU - Federazione Russa 1.237
DE - Germania 1.184
VN - Vietnam 1.147
BR - Brasile 1.056
SE - Svezia 859
CA - Canada 816
IE - Irlanda 719
UA - Ucraina 452
GB - Regno Unito 398
FR - Francia 319
IN - India 301
FI - Finlandia 201
BD - Bangladesh 171
KR - Corea 167
AR - Argentina 142
TR - Turchia 106
IQ - Iraq 104
ID - Indonesia 103
ZA - Sudafrica 85
NL - Olanda 83
ES - Italia 77
MX - Messico 76
PK - Pakistan 69
PL - Polonia 68
EC - Ecuador 60
AT - Austria 58
JP - Giappone 58
CO - Colombia 56
PH - Filippine 52
SA - Arabia Saudita 51
DK - Danimarca 49
UZ - Uzbekistan 48
VE - Venezuela 36
CL - Cile 32
MA - Marocco 27
EG - Egitto 25
CZ - Repubblica Ceca 24
KE - Kenya 24
BE - Belgio 20
AZ - Azerbaigian 19
IR - Iran 18
JO - Giordania 18
MY - Malesia 18
PY - Paraguay 18
RO - Romania 18
AE - Emirati Arabi Uniti 16
PE - Perù 16
AU - Australia 15
LB - Libano 15
TN - Tunisia 15
ET - Etiopia 14
AL - Albania 13
LT - Lituania 13
TH - Thailandia 13
TW - Taiwan 12
CH - Svizzera 11
DZ - Algeria 11
EU - Europa 11
JM - Giamaica 11
UY - Uruguay 11
IL - Israele 10
KZ - Kazakistan 10
OM - Oman 10
PA - Panama 10
BG - Bulgaria 9
NP - Nepal 9
BH - Bahrain 8
DO - Repubblica Dominicana 8
PT - Portogallo 8
TT - Trinidad e Tobago 8
HN - Honduras 7
PS - Palestinian Territory 7
SN - Senegal 7
BO - Bolivia 6
GR - Grecia 6
HU - Ungheria 6
KH - Cambogia 6
LK - Sri Lanka 6
LV - Lettonia 6
BY - Bielorussia 5
CI - Costa d'Avorio 5
EE - Estonia 5
SY - Repubblica araba siriana 5
BB - Barbados 4
CR - Costa Rica 4
GE - Georgia 4
GT - Guatemala 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BJ - Benin 3
LA - Repubblica Popolare Democratica del Laos 3
LY - Libia 3
QA - Qatar 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 34.974
Salva come PNG Salva come JPEG
Città #
Singapore 2.086
Ann Arbor 1.953
Ashburn 1.446
Hong Kong 1.287
San Jose 1.259
Woodbridge 944
Fairfield 824
Houston 783
Frankfurt am Main 732
Chandler 709
Dublin 679
Toronto 620
Wilmington 490
New York 471
Jacksonville 467
Dearborn 435
Milan 391
Seattle 378
Beijing 359
Santa Clara 347
Ho Chi Minh City 316
Hanoi 295
Hefei 294
Chicago 283
Cambridge 268
Dallas 244
Princeton 244
Los Angeles 241
The Dalles 164
Seoul 158
Lauterbourg 138
Nanjing 130
Moscow 126
Shanghai 123
Altamura 122
Lawrence 117
Buffalo 102
São Paulo 93
Munich 90
Council Bluffs 85
Lachine 80
San Diego 77
Helsinki 76
Orem 76
Guangzhou 62
Da Nang 55
London 54
Nanchang 52
Haiphong 51
Jakarta 50
Baghdad 49
Rome 49
Warsaw 49
Boardman 46
Andover 43
Tokyo 42
Tashkent 40
Brooklyn 39
Chennai 38
Dong Ket 38
Fremont 38
Johannesburg 38
Montreal 38
Tianjin 38
Rio de Janeiro 37
Hebei 36
Atlanta 35
Nuremberg 34
Shenyang 34
Salt Lake City 33
Vienna 33
Denver 31
Falls Church 31
Lissone 31
Turku 29
Changsha 27
Manchester 27
Phoenix 27
Amsterdam 26
Dhaka 26
Monza 25
Mumbai 24
Ottawa 24
Stockholm 24
Jiaxing 22
Kunming 22
New Delhi 22
Poplar 22
Columbus 21
Jinan 21
Ningbo 21
Quito 21
Belo Horizonte 20
Nürnberg 20
Zhengzhou 20
Porto Alegre 19
Brno 18
Buenos Aires 18
Nairobi 18
Norwalk 18
Totale 22.428
Salva come PNG Salva come JPEG
Nome #
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 474
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 404
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 359
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 351
Differing associations for sport versus occupational physical activity and cardiovascular risk 351
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 329
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 328
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 328
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 319
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 315
The Pamela study: main findings and perspectives 307
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 303
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 297
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 294
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 291
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 291
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 290
Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population 287
HYPERTENSIVE EMERGENCIES AND URGENCIES: ADHERENCE TO GUIDELIENS AND RELATIONSHIP BETWEEN BLOOD PRESSURE MANAGEMENT AND IN-HOSPITAL MORTALITY 285
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 283
Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) 279
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 279
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 274
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study 269
New-onset left atrial enlargement in a general population 268
Neuroadrenergic disarray in pseudo-resistant and resistant hypertension 268
Combined effects of hypertension and hypercholesterolemia on radial artery function 267
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 266
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 266
Accuracy evaluation of the 'Cardiette BP one' ambulatory blood pressure monitor 266
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 266
Role of ambulatory blood pressure monitoring in resistant hypertension 265
The association between 24-h blood pressure patterns and left ventricular mechanics 264
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 263
Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure 261
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 261
Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population 260
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 260
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 259
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 259
Blood pressure variability and organ damage in a general population: Results from the PAMELA study 258
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 258
Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population 257
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 253
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 250
IMPORTANCE OF URIC ACID THRESHOLD IN ITS CORRELATION WITH METABOLIC SYNDROME 248
Comparison of the new alpha 1-blocker alfuzosin with propranolol as first-line therapy in hypertension 246
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 246
Simultaneous validation of the SunTech 247 diagnostic station blood pressure measurement device according to the British hypertension society protocol, the international protocol and the association for the advancement of medical instrumentation standards 244
Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: The PAMELA Study 244
C68 RESTING HEART RATE AND ARTERIAL STIFFNESS: A LONGITUDINAL PROSPECTIVE STUDY IN A POPULATION OF HYPERTENSIVE PATIENTS 243
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in 243
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 241
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 240
Diurnal blood pressure variation and sympathetic activity 239
Should white-coat hypertension in diabetes be treated? Pro 237
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 237
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study 237
HIV and metabolic syndrome - A comparison with the general population 236
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 234
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 233
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 233
Importance of uric acid threshold in its correlation with metabolic syndrome 232
The Pamela Study: Old and New Findings 231
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 230
Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: Data from the PAMELA study 230
Prognostic value of "partial" and "true" white coat hypertension: data from 16 year follow-up in the PAMELA population 229
Neurological hypertensive emergencies: Correlation of blood pressure values with in-hospital outcomes in ischemic stroke 227
Predictive value of different indices of blood pressure variability on 227
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 227
Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project) 226
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 226
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 226
Resting Heart Rate and Arterial Stiffness: a Longitudinal Prospective Study in a Population of Hypertensive Patients 222
Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage 222
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 220
Long-term risk of sustained hypertension in white-coat or masked hypertension 219
Metabolic Syndrome is Related to Vascular Structural Alterations But Not to Functional one both in Hypertensives and Healthy Subjects in Selected abstracts from the XXXVIII National Congress of the Italian Society of Hypertension (SIIA) 218
Long-term prognistic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements 218
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 216
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy 215
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 214
Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? 214
Incidence and risk factors for delayed intracranial hemorrhage after mild brain injury in anticoagulated patients: a multicenter retrospective study 212
Aortic root diameter and risk of cardiovascular events in a general population: data from the PAMELA study 210
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study 208
Metabolic syndrome is related to vascular structural alterations but not to functional ones both in hypertensives and healthy subjects 207
Diagnosis and management of patients with white-coat and masked hypertension 206
Aortic root diameter and risk of cardiovascular events in a general population: the PAMELA study 206
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population: The PAMELA study 206
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 204
Do reverse dippers have the highest risk of right ventricular remodeling? 204
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 203
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis 202
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study 201
Williams syndrome is associated with an increase in heart rate and wave reflection values during the nighttime period. 201
Association between ADRA1A gene and the metabolic syndrome: Candidate genes and functional counterpart in the PAMELA population 198
Bloodstream infections due to multi-drug resistant bacteria in the emergency department: prevalence, risk factors and outcomes—a retrospective observational study 197
Nighttime Blood Pressure and New-Onset Left Ventricular Hypertrophy: Findings From the Pamela Population 196
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 194
Totale 25.307
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.038
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021317 0 0 0 0 0 0 0 0 0 0 114 203
2021/20221.706 109 159 172 182 148 144 63 76 104 114 129 306
2022/20233.123 312 901 277 258 214 468 53 207 183 56 114 80
2023/20242.396 62 71 104 123 298 598 457 91 232 43 35 282
2024/20256.152 319 718 285 281 476 170 269 274 570 858 737 1.195
2025/202613.281 1.463 858 1.083 1.505 1.539 703 2.148 605 1.130 1.328 919 0
Totale 35.676